Drug intelligence / Profile preview

Xinluosu + red yeast rice

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

This combination involves Xinluosu, which is not explicitly defined in the provided context, and red yeast rice, a traditional Chinese dietary supplement known for its potential to lower cholesterol levels due to its content of monacolin K, a statin-like compound. Red yeast rice is used to improve cardiovascular health by reducing LDL cholesterol and has been associated with potential side effects similar to statins, such as liver damage and muscle pain.

Other names: 新络素 + 红曲

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Xinluosu + red yeast rice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinluosu + red yeast rice.

Explore the full profile